Communicable disease surveillance ethics in the age of big data and new technology

Gwendolyn L. Gilbert, Chris Degeling, Jane Johnson

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Surveillance is essential for communicable disease prevention and control. Traditional notification of demographic and clinical information, about individuals with selected (notifiable) infectious diseases, allows appropriate public health action and is protected by public health and privacy legislation, but is slow and insensitive. Big data–based electronic surveillance, by commercial bodies and government agencies (for profit or population control), which draws on a plethora of internet- and mobile device–based sources, has been widely accepted, if not universally welcomed. Similar anonymous digital sources also contain syndromic information, which can be analysed, using customised algorithms, to rapidly predict infectious disease outbreaks, but the data are nonspecific and predictions sometimes misleading. However, public health authorities could use these online sources, in combination with de-identified personal health data, to provide more accurate and earlier warning of infectious disease events—including exotic or emerging infections—even before the cause is confirmed, and allow more timely public health intervention. Achieving optimal benefits would require access to selected data from personal electronic health and laboratory (including pathogen genomic) records and the potential to (confidentially) re-identify individuals found to be involved in outbreaks, to ensure appropriate care and infection control. Despite existing widespread digital surveillance and major potential community benefits of extending its use to communicable disease control, there is considerable public disquiet about allowing public health authorities access to personal health data. Informed public discussion, greater transparency and an ethical framework will be essential to build public trust in the use of new technology for communicable disease control.

LanguageEnglish
Pages173-187
Number of pages15
JournalAsian Bioethics Review
Volume11
Issue number2
DOIs
Publication statusPublished - Jun 2019
Externally publishedYes

Fingerprint

communicable disease
Ethics
Communicable Diseases
surveillance
new technology
Communicable Disease Control
Public Health
public health
moral philosophy
Technology
contagious disease
Disease Outbreaks
Health
health
electronics
Government Agencies
Population Control
Privacy
Infection Control
government agency

Bibliographical note

Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Big Data
  • Communicable Disease Surveillance
  • Electronic Medical Records
  • Pathogen Genomics

Cite this

Gilbert, Gwendolyn L. ; Degeling, Chris ; Johnson, Jane. / Communicable disease surveillance ethics in the age of big data and new technology. In: Asian Bioethics Review. 2019 ; Vol. 11, No. 2. pp. 173-187.
@article{c3f7dff4f54149d1abf0fa96b65671f6,
title = "Communicable disease surveillance ethics in the age of big data and new technology",
abstract = "Surveillance is essential for communicable disease prevention and control. Traditional notification of demographic and clinical information, about individuals with selected (notifiable) infectious diseases, allows appropriate public health action and is protected by public health and privacy legislation, but is slow and insensitive. Big data–based electronic surveillance, by commercial bodies and government agencies (for profit or population control), which draws on a plethora of internet- and mobile device–based sources, has been widely accepted, if not universally welcomed. Similar anonymous digital sources also contain syndromic information, which can be analysed, using customised algorithms, to rapidly predict infectious disease outbreaks, but the data are nonspecific and predictions sometimes misleading. However, public health authorities could use these online sources, in combination with de-identified personal health data, to provide more accurate and earlier warning of infectious disease events—including exotic or emerging infections—even before the cause is confirmed, and allow more timely public health intervention. Achieving optimal benefits would require access to selected data from personal electronic health and laboratory (including pathogen genomic) records and the potential to (confidentially) re-identify individuals found to be involved in outbreaks, to ensure appropriate care and infection control. Despite existing widespread digital surveillance and major potential community benefits of extending its use to communicable disease control, there is considerable public disquiet about allowing public health authorities access to personal health data. Informed public discussion, greater transparency and an ethical framework will be essential to build public trust in the use of new technology for communicable disease control.",
keywords = "Big Data, Communicable Disease Surveillance, Electronic Medical Records, Pathogen Genomics",
author = "Gilbert, {Gwendolyn L.} and Chris Degeling and Jane Johnson",
note = "Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",
year = "2019",
month = "6",
doi = "10.1007/s41649-019-00087-1",
language = "English",
volume = "11",
pages = "173--187",
journal = "Asian Bioethics Review",
issn = "1793-9453",
publisher = "National University of Singapore, Department of Biological Sciences, Centre for Biomedical Ethics",
number = "2",

}

Communicable disease surveillance ethics in the age of big data and new technology. / Gilbert, Gwendolyn L.; Degeling, Chris; Johnson, Jane.

In: Asian Bioethics Review, Vol. 11, No. 2, 06.2019, p. 173-187.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Communicable disease surveillance ethics in the age of big data and new technology

AU - Gilbert, Gwendolyn L.

AU - Degeling, Chris

AU - Johnson, Jane

N1 - Copyright the Author(s) 2019. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2019/6

Y1 - 2019/6

N2 - Surveillance is essential for communicable disease prevention and control. Traditional notification of demographic and clinical information, about individuals with selected (notifiable) infectious diseases, allows appropriate public health action and is protected by public health and privacy legislation, but is slow and insensitive. Big data–based electronic surveillance, by commercial bodies and government agencies (for profit or population control), which draws on a plethora of internet- and mobile device–based sources, has been widely accepted, if not universally welcomed. Similar anonymous digital sources also contain syndromic information, which can be analysed, using customised algorithms, to rapidly predict infectious disease outbreaks, but the data are nonspecific and predictions sometimes misleading. However, public health authorities could use these online sources, in combination with de-identified personal health data, to provide more accurate and earlier warning of infectious disease events—including exotic or emerging infections—even before the cause is confirmed, and allow more timely public health intervention. Achieving optimal benefits would require access to selected data from personal electronic health and laboratory (including pathogen genomic) records and the potential to (confidentially) re-identify individuals found to be involved in outbreaks, to ensure appropriate care and infection control. Despite existing widespread digital surveillance and major potential community benefits of extending its use to communicable disease control, there is considerable public disquiet about allowing public health authorities access to personal health data. Informed public discussion, greater transparency and an ethical framework will be essential to build public trust in the use of new technology for communicable disease control.

AB - Surveillance is essential for communicable disease prevention and control. Traditional notification of demographic and clinical information, about individuals with selected (notifiable) infectious diseases, allows appropriate public health action and is protected by public health and privacy legislation, but is slow and insensitive. Big data–based electronic surveillance, by commercial bodies and government agencies (for profit or population control), which draws on a plethora of internet- and mobile device–based sources, has been widely accepted, if not universally welcomed. Similar anonymous digital sources also contain syndromic information, which can be analysed, using customised algorithms, to rapidly predict infectious disease outbreaks, but the data are nonspecific and predictions sometimes misleading. However, public health authorities could use these online sources, in combination with de-identified personal health data, to provide more accurate and earlier warning of infectious disease events—including exotic or emerging infections—even before the cause is confirmed, and allow more timely public health intervention. Achieving optimal benefits would require access to selected data from personal electronic health and laboratory (including pathogen genomic) records and the potential to (confidentially) re-identify individuals found to be involved in outbreaks, to ensure appropriate care and infection control. Despite existing widespread digital surveillance and major potential community benefits of extending its use to communicable disease control, there is considerable public disquiet about allowing public health authorities access to personal health data. Informed public discussion, greater transparency and an ethical framework will be essential to build public trust in the use of new technology for communicable disease control.

KW - Big Data

KW - Communicable Disease Surveillance

KW - Electronic Medical Records

KW - Pathogen Genomics

UR - http://www.scopus.com/inward/record.url?scp=85067297424&partnerID=8YFLogxK

U2 - 10.1007/s41649-019-00087-1

DO - 10.1007/s41649-019-00087-1

M3 - Article

VL - 11

SP - 173

EP - 187

JO - Asian Bioethics Review

T2 - Asian Bioethics Review

JF - Asian Bioethics Review

SN - 1793-9453

IS - 2

ER -